Anupam Rama
Stock Analyst at J.P. Morgan
(4.87)
# 350
Out of 5,090 analysts
799
Total ratings
48.2%
Success rate
22%
Average return
Main Sectors:
Stocks Rated by Anupam Rama
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals International, | Rated: Buy | $107 → $122 | $92.24 | +32.26% | 26 | Oct 30, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | n/a | $31.96 | - | 39 | Oct 26, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | n/a | $31.48 | - | 12 | Oct 26, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | n/a | $6.20 | - | 18 | Oct 15, 2026 | |
| ORIC ORIC Pharmaceuticals | Rated: Buy | $23 → $26 | $9.24 | +181.39% | 32 | Oct 14, 2026 | |
| TRAX First Tracks Biotherapeutics | Reiterated: Buy | n/a | $45.08 | - | 5 | Oct 12, 2026 | |
| CCCC C4 Therapeutics | Initiated Coverage: Buy | $10 | $3.37 | +196.74% | 1 | Oct 9, 2026 | |
| ANAB AnaptysBio | Rated: Buy | $70 → $60 | $48.28 | +24.28% | 35 | Sep 30, 2026 | |
| ANNX Annexon | Rated: Buy | $14 → $15 | $4.05 | +270.37% | 22 | Sep 30, 2026 | |
| SRPT Sarepta Therapeutics | Rated: Hold | $20 | $18.62 | +7.41% | 66 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $99.18 | - | 24 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $157 | $69.13 | +127.11% | 1 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $30.98 | - | 35 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.49 | - | 2 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.00 | - | 32 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $31.02 | +99.87% | 17 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $80 → $36 | $16.10 | +123.60% | 32 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $14.35 | +129.97% | 14 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $22.07 | +63.12% | 23 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $21 | $17.61 | +19.25% | 35 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $51 → $46 | $14.13 | +225.55% | 2 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.34 | +370.09% | 14 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.30 | - | 6 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $100 → $111 | $74.95 | +48.10% | 43 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $40 | $13.65 | +193.04% | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $217 | $146.10 | +48.53% | 66 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $90 | $50.39 | +78.61% | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9 | $3.96 | +127.27% | 3 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $3.71 | - | 5 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.6395 | - | 2 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $10.71 | +77.40% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $19.68 | +103.25% | 2 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $10.08 | -40.48% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.54 | n/a | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $204 → $170 | $165.00 | n/a | 14 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $2.03 | n/a | 11 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | - | n/a | 11 | Nov 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $27 → $5 | $8.01 | n/a | 6 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $64 | $62.99 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $48 | $30.55 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $8 | $96.56 | n/a | 3 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $45 | $144.85 | n/a | 6 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.45 | n/a | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $43.90 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $30 → $37 | $11.30 | n/a | 6 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 | $0.000001 | n/a | 8 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $56 → $10 | $14.32 | n/a | 5 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $16.69 | n/a | 1 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $1.66 | n/a | 2 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $51.31 | n/a | 9 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $59.97 | n/a | 10 | Nov 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $195.54 | n/a | 1 | Sep 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $3.50 | n/a | 10 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $15.16 | n/a | 4 | Jun 15, 2016 |
Kiniksa Pharmaceuticals International,
Oct 30, 2026
Rated: Buy
Price Target: $107 → $122
Current: $92.24
Upside: +32.26%
IDEAYA Biosciences
Oct 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.96
Upside: -
Maze Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.48
Upside: -
Solid Biosciences
Oct 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.20
Upside: -
ORIC Pharmaceuticals
Oct 14, 2026
Rated: Buy
Price Target: $23 → $26
Current: $9.24
Upside: +181.39%
First Tracks Biotherapeutics
Oct 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $45.08
Upside: -
C4 Therapeutics
Oct 9, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $3.37
Upside: +196.74%
AnaptysBio
Sep 30, 2026
Rated: Buy
Price Target: $70 → $60
Current: $48.28
Upside: +24.28%
Annexon
Sep 30, 2026
Rated: Buy
Price Target: $14 → $15
Current: $4.05
Upside: +270.37%
Sarepta Therapeutics
Sep 30, 2026
Rated: Hold
Price Target: $20
Current: $18.62
Upside: +7.41%
Sep 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $99.18
Upside: -
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $157
Current: $69.13
Upside: +127.11%
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.98
Upside: -
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.49
Upside: -
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.00
Upside: -
Sep 9, 2026
Reiterated: Buy
Price Target: $62
Current: $31.02
Upside: +99.87%
Sep 3, 2026
Downgraded: Hold
Price Target: $80 → $36
Current: $16.10
Upside: +123.60%
Sep 1, 2026
Reiterated: Buy
Price Target: $33
Current: $14.35
Upside: +129.97%
Sep 1, 2026
Reiterated: Buy
Price Target: $36
Current: $22.07
Upside: +63.12%
Aug 26, 2026
Rated: Buy
Price Target: $20 → $21
Current: $17.61
Upside: +19.25%
Aug 25, 2026
Rated: Buy
Price Target: $51 → $46
Current: $14.13
Upside: +225.55%
Aug 17, 2026
Reiterated: Buy
Price Target: $11
Current: $2.34
Upside: +370.09%
Aug 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.30
Upside: -
Aug 12, 2026
Rated: Buy
Price Target: $100 → $111
Current: $74.95
Upside: +48.10%
Aug 11, 2026
Reiterated: Buy
Price Target: $45 → $40
Current: $13.65
Upside: +193.04%
Aug 6, 2026
Reiterated: Buy
Price Target: $217
Current: $146.10
Upside: +48.53%
Aug 6, 2026
Reiterated: Buy
Price Target: $53 → $90
Current: $50.39
Upside: +78.61%
Jun 22, 2026
Upgraded: Buy
Price Target: $9
Current: $3.96
Upside: +127.27%
Jun 2, 2026
Downgraded: Sell
Price Target: n/a
Current: $3.71
Upside: -
Mar 24, 2026
Reiterated: Sell
Price Target: n/a
Current: $0.6395
Upside: -
Mar 3, 2026
Reiterated: Buy
Price Target: $19
Current: $10.71
Upside: +77.40%
Dec 18, 2025
Reiterated: Buy
Price Target: $40
Current: $19.68
Upside: +103.25%
Nov 18, 2025
Reiterated: Sell
Price Target: $6
Current: $10.08
Upside: -40.48%
May 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $15.54
Upside: n/a
Feb 1, 2024
Reiterated: Hold
Price Target: $204 → $170
Current: $165.00
Upside: n/a
Dec 22, 2023
Downgraded: Sell
Price Target: n/a
Current: $2.03
Upside: n/a
Nov 13, 2022
Downgraded: Sell
Price Target: n/a
Current: -
Upside: n/a
Aug 15, 2022
Reiterated: Hold
Price Target: $27 → $5
Current: $8.01
Upside: n/a
May 11, 2022
Reiterated: Buy
Price Target: $55 → $64
Current: $62.99
Upside: n/a
May 10, 2022
Reiterated: Hold
Price Target: $50 → $48
Current: $30.55
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $9 → $8
Current: $96.56
Upside: n/a
May 6, 2022
Reiterated: Buy
Price Target: $51 → $45
Current: $144.85
Upside: n/a
Mar 8, 2022
Downgraded: Hold
Price Target: n/a
Current: $3.45
Upside: n/a
Nov 12, 2021
Reiterated: Buy
Price Target: $55
Current: $43.90
Upside: n/a
Oct 25, 2021
Upgraded: Hold
Price Target: $30 → $37
Current: $11.30
Upside: n/a
Aug 5, 2021
Upgraded: Buy
Price Target: $6
Current: $0.000001
Upside: n/a
Mar 25, 2021
Downgraded: Sell
Price Target: $56 → $10
Current: $14.32
Upside: n/a
Oct 12, 2020
Initiated Coverage: Buy
Price Target: $27
Current: $16.69
Upside: n/a
Jun 5, 2019
Downgraded: Sell
Price Target: n/a
Current: $1.66
Upside: n/a
Mar 1, 2019
Reiterated: Buy
Price Target: $7 → $6
Current: $51.31
Upside: n/a
Nov 16, 2017
Upgraded: Hold
Price Target: n/a
Current: $59.97
Upside: n/a
Sep 29, 2017
Reiterated: Hold
Price Target: n/a
Current: $195.54
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $20 → $19
Current: $3.50
Upside: n/a
Jun 15, 2016
Reiterated: Hold
Price Target: n/a
Current: $15.16
Upside: n/a